92 related articles for article (PubMed ID: 16316775)
1. Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy.
Kunkel M; Helisch A; Reichert TE; Jeong JH; Buchholz HG; Benz P; Bartenstein P; Wagner W; Whiteside TL
Oral Oncol; 2006 Mar; 42(3):297-305. PubMed ID: 16316775
[TBL] [Abstract][Full Text] [Related]
2. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
Kunkel M; Förster GJ; Reichert TE; Jeong JH; Benz P; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Nov; 98(10):2257-65. PubMed ID: 14601097
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; See LC; Yen TC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):764-71. PubMed ID: 18835509
[TBL] [Abstract][Full Text] [Related]
4. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
Hofele C; Freier K; Thiele OC; Haberkorn U; Buchmann I
Oral Oncol; 2009 Nov; 45(11):963-7. PubMed ID: 19665923
[TBL] [Abstract][Full Text] [Related]
5. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma.
Suzuki H; Hasegawa Y; Terada A; Hyodo I; Nakashima T; Nishio M; Tamaki T
Oral Oncol; 2009 Jul; 45(7):569-73. PubMed ID: 18804407
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
[TBL] [Abstract][Full Text] [Related]
8. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096
[TBL] [Abstract][Full Text] [Related]
9. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
[TBL] [Abstract][Full Text] [Related]
10. Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.
Liao CT; Fan KH; Lin CY; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Hsueh C; Lee LY; Lin CH; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):944-55. PubMed ID: 22434050
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy.
Shimizu M; Mitsudo K; Koike I; Taguri M; Iwai T; Koizumi T; Oguri S; Kioi M; Hirota M; Inoue T; Tohnai I
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):239-47. PubMed ID: 26768076
[TBL] [Abstract][Full Text] [Related]
12. Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse.
Liao CT; Chang JT; Wang HM; Ng SH; Huang SF; Chen IH; Hsueh C; Lee LY; Lin CH; Cheng AJ; Yen TC
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1783-93. PubMed ID: 19495747
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
14. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
15. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
[TBL] [Abstract][Full Text] [Related]
16. Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
Krabbe CA; van der Werff-Regelink G; Pruim J; van der Wal JE; Roodenburg JL
Head Neck; 2010 Mar; 32(3):368-74. PubMed ID: 19626632
[TBL] [Abstract][Full Text] [Related]
17. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas.
Suzuki H; Fukuyama R; Hasegawa Y; Tamaki T; Nishio M; Nakashima T; Tatematsu M
Oral Oncol; 2009 Oct; 45(10):891-7. PubMed ID: 19457711
[TBL] [Abstract][Full Text] [Related]
18. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
[TBL] [Abstract][Full Text] [Related]
19. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
